We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$369B
AUM Growth
-$12.6B
(-3.3%)
Cap. Flow
+$3.24B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
31.8%
Holding
3,300
New
48
Increased
1,756
Reduced
1,134
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.25B |
| 2 |
NXUS
Nuveen International Aggregate Bond ETF
NXUS
|
+$938M |
| 3 |
Apple
AAPL
|
+$911M |
| 4 |
Costco
COST
|
+$878M |
| 5 |
NVIDIA
NVDA
|
+$799M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.69B |
| 2 |
ServiceNow
NOW
|
+$651M |
| 3 |
Applied Materials
AMAT
|
+$563M |
| 4 |
Visa
V
|
+$536M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$523M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.9% |
| 2 | Financials | 11.41% |
| 3 | Consumer Discretionary | 10.18% |
| 4 | Industrials | 9.65% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Savara
SVRA
$1.13B
| $1.88M | ﹤0.01% |
343,553
+70,951
| +26% | +$395K |
|
2277
Atlas Energy Solutions
AESI
$1.49B
| $1.87M | ﹤0.01% |
142,416
-6,493
| -4% | -$75.9K |
|
2278
National Beverage
FIZZ
$2.87B
| $1.87M | ﹤0.01% |
55,454
+3,085
| +6% | +$107K |
|
|
DOO
2279
Bombardier Recreational Products
DOO
$4.43B
| $1.86M | ﹤0.01% |
26,026
| – | – |
|
2280
American Express Global Business Travel
GBTG
$4.91B
| $1.86M | ﹤0.01% |
333,781
-4,822
| -1% | -$29.9K |
|
2281
Driven Brands
DRVN
$2.25B
| $1.86M | ﹤0.01% |
147,686
-5,386
| -4% | -$75.8K |
|
|
ORC
2282
Orchid Island Capital
ORC
$1.31B
| $1.84M | ﹤0.01% |
262,173
+71,663
| +38% | +$541K |
|
2283
Vestis
VSTS
$2.06B
| $1.84M | ﹤0.01% |
234,258
-30,308
| -11% | -$221K |
|
|
RHLD
2284
Resolute Holdings Management
RHLD
$1.09B
| $1.83M | ﹤0.01% |
11,276
+83
| +0.7% | +$15.1K |
|
2285
Concentrix
CNXC
$1.36B
| $1.81M | ﹤0.01% |
66,325
-165,369
| -71% | -$5.87M |
|
2286
Vital Farms
VITL
$558M
| $1.81M | ﹤0.01% |
128,403
+270
| +0.2% | +$6.38K |
|
2287
Financial Institutions
FISI
$800M
| $1.8M | ﹤0.01% |
56,857
+19,831
| +54% | +$638K |
|
2288
Revolve Group
RVLV
$1.79B
| $1.8M | ﹤0.01% |
79,485
-296,253
| -79% | -$7.77M |
|
2289
Zevra Therapeutics
ZVRA
$563M
| $1.79M | ﹤0.01% |
192,588
+49,456
| +35% | +$446K |
|
2290
Prudential
PUK
$36.5B
| $1.79M | ﹤0.01% |
63,052
-2,009
| -3% | -$61.9K |
|
2291
Amerant Bancorp
AMTB
$1.12B
| $1.79M | ﹤0.01% |
81,329
+444
| +0.5% | +$9.53K |
|
2292
Hafnia
HAFN
$3.82B
| $1.78M | ﹤0.01% |
232,951
| – | – |
|
|
PENG
2293
Penguin Solutions Inc
PENG
$2.76B
| $1.77M | ﹤0.01% |
100,733
-2,718
| -3% | -$51.7K |
|
2294
Horizon Bancorp
HBNC
$1.03B
| $1.76M | ﹤0.01% |
106,179
-115,078
| -52% | -$1.97M |
|
2295
ATS Corp
ATS
$2.56B
| $1.76M | ﹤0.01% |
62,584
| – | – |
|
2296
Legend Biotech
LEGN
$4.3B
| $1.75M | ﹤0.01% |
96,786
+2,200
| +2% | +$41.9K |
|
2297
Anika Therapeutics
ANIK
$199M
| $1.75M | ﹤0.01% |
120,717
+67,515
| +127% | +$784K |
|
|
SVM
2298
Silvercorp Metals
SVM
$2.13B
| $1.75M | ﹤0.01% |
162,896
| – | – |
|
|
SAFE
2299
Safehold
SAFE
$1.19B
| $1.75M | ﹤0.01% |
129,044
+886
| +0.7% | +$13.1K |
|
|
GLIBK
2300
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$876M
| $1.74M | ﹤0.01% |
46,630
+346
| +0.7% | +$13.1K |
|
Similar funds
VFT
Nuveen's Q1 2026 Portfolio in Review
As of Q1 2026, Nuveen held 3,300 positions worth $369B, down 3.3% from $382B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 3.8%. Nuveen opened 48 new positions and exited 76, leaving the 3,300-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,483,995 shares worth $156M.
- Nuveen added most to AstraZeneca in Q1 2026, an estimated $1.25B increase.
- Nuveen's biggest Q1 2026 reduction was Microsoft, cutting an estimated $1.69B.
- Nuveen fully exited Exact Sciences in Q1 2026, selling an estimated $82.6M.
- Nuveen's ten largest holdings make up 32% of its $369B portfolio in Q1 2026.
- Nuveen opened 48 new positions and closed 76 in Q1 2026.
- Nuveen's portfolio value fell 3.3% quarter-over-quarter to $369B.
Based on Nuveen's 13F filing for Q1 2026, filed 30 Apr 2026.